Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q _____________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-40384 __________________________________________________________ TOURMALINE BIO, INC. (Exact name of Registrant a ...

Back to Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number 1-2958 HUBBELL INCORPORATED (Exact name of registrant as specified in its charter) (State or other ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________________________________________________ FORM 10-Q ____________________________________________________________________________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2025 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (Address of principal executive offices) (Zip code) Registrant's telephone number, including area code: (312) 630-1900 Commission file number 001-14157 TEL ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 2, 2025 iBio, Inc. (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-35023 26-2797813 (Commission File Number) (IRS Employer Identification No.) | Title of each class | Trading Symbol(s) | Name of each exchange on which | | --- | ...

Exhibit 99.1 Vislink Reports Fourth Quarter and Full Year 2024 Financial and Operational Results Mt. Olive, NJ — May 2, 2025 — Vislink Technologies, Inc. ("Vislink" or the "Company") (OTCQB: VISL), a global technology leader in the capture, delivery, and management of high-quality live video and associated data in the media and entertainment, law enforcement, and defense markets, today reported results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 and Recent Company Highl ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLOG ...

Financial Performance - AAM's sales for Q1 2025 were $1.41 billion, down from $1.61 billion in Q1 2024, reflecting a decrease in overall volumes [4]. - Net income for Q1 2025 was $7.1 million, or 0.5% of sales, compared to $20.5 million, or 1.3% of sales in Q1 2024 [5]. - Adjusted EBITDA for Q1 2025 was $177.3 million, or 12.6% of sales, down from $205.6 million, or 12.8% of sales in Q1 2024 [6]. - Net sales for Q1 2025 were $1,411.3 million, a decrease of 12.1% compared to $1,606.9 million in Q1 2024 [28]. - Gross profit for Q1 2025 was $173.9 million, down from $198.5 million in Q1 2024, reflecting a gross margin of 12.3% [28]. - Operating income decreased to $42.7 million in Q1 2025 from $77.0 million in Q1 2024, representing a decline of 44.5% [28]. - Net income for Q1 2025 was $7.1 million, significantly lower than $20.5 million in Q1 2024, resulting in diluted earnings per share of $0.06 compared to $0.17 [28][36]. - Adjusted EBITDA for Q1 2025 was $177.3 million, down from $205.6 million in Q1 2024, indicating a decrease of 13.7% [34]. - Free cash flow for Q1 2025 was negative at $(12.8) million, an improvement from $(27.1) million in Q1 2024 [40]. Cash Flow and Outlook - AAM's net cash provided by operating activities for Q1 2025 was $55.9 million, significantly higher than $17.8 million in Q1 2024 [6]. - Adjusted free cash flow for Q1 2025 was $(3.9) million, an improvement from $(21.4) million in Q1 2024 [7]. - AAM's updated financial outlook for 2025 targets sales between $5.65 billion and $5.95 billion, down from a previous range of $5.8 billion to $6.05 billion [17]. - The company is targeting Adjusted EBITDA in the range of $665 million to $745 million for 2025, revised from $700 million to $760 million [17]. - AAM anticipates Adjusted free cash flow for 2025 to be between $165 million and $215 million, down from a prior target of $200 million to $230 million [17]. - Net cash provided by operating activities is estimated to be between $375 million and $425 million [45]. - Full year 2025 targeted Free Cash Flow is expected to be between $75 million and $125 million [45]. - Full year 2025 targeted Adjusted Free Cash Flow is anticipated to range from $165 million to $215 million [45]. Assets and Liabilities - Total assets increased to $5,139.4 million as of March 31, 2025, compared to $5,059.9 million at the end of 2024 [30]. - Total liabilities rose to $4,543.1 million as of March 31, 2025, up from $4,497.1 million at the end of 2024 [30]. Costs and Expenses - The company reported a restructuring and acquisition-related cost of $19.7 million in Q1 2025, compared to $2.5 million in Q1 2024 [28]. - Interest expense for the period is projected to be between $170 million and $180 million [45]. - Depreciation and amortization costs are expected to remain constant at $455 million [45]. - Restructuring-related costs are estimated at $25 million for the year [45]. - Dowlais acquisition-related costs are projected to be $65 million [45]. - Income tax expense is expected to be between $35 million and $50 million [45]. Production and Sales Segments - North American light vehicle production is estimated to be approximately 14.0 to 15.1 million units for 2025 [17]. - Segment sales for Driveline were $957.8 million in Q1 2025, down from $1,106.4 million in Q1 2024, while Metal Forming sales decreased to $575.8 million from $644.1 million [42].

Table of Contents U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 000-26719 MERCANTILE BANK CORPORATION (Exact name of registrant as specified in its charter) Michigan 38-3360865 (State or other jurisdictio ...

Financial Performance - Net income for Q1 2025 was $1,288 million, an increase of $93 million from Q1 2024, with diluted earnings per share rising to $2.52 from $2.23[3] - Total revenues for Q1 2025 were CAD 12,517 million, an increase from CAD 12,283 million in Q1 2024, representing a growth of 1.9%[39] - Net income for Q1 2025 was CAD 1,288 million, compared to CAD 1,195 million in Q1 2024, reflecting an increase of 7.8%[39] - Earnings per share (diluted) for Q1 2025 were CAD 2.52, up from CAD 2.23 in Q1 2024, indicating a growth of 13.0%[39] - Total expenses for Q1 2025 were CAD 10,829 million, slightly up from CAD 10,711 million in Q1 2024, indicating a 1.1% increase[62] Cash Flow and Dividends - Cash flows from operating activities were $1,527 million, up from $1,076 million in Q1 2024, while cash flows excluding working capital increased to $1,760 million from $1,521 million[11] - The company returned $307 million to shareholders through dividends in Q1 2025, with a declared second quarter dividend of $0.72 per share[7] - Dividends declared on common stock increased to CAD 367 million in Q1 2025 from CAD 321 million in Q1 2024, representing a growth of 14.3%[39] - Free cash flow for Q1 2025 was CAD 1,150 million, significantly higher than CAD 595 million in Q1 2024, representing a 93% increase[58] Production and Operations - Upstream production averaged 418,000 gross oil-equivalent barrels per day, with Kearl production at 256,000 barrels per day, down from 277,000 barrels per day in Q1 2024 due to extreme cold weather[11] - Downstream throughput averaged 397,000 barrels per day, with refinery capacity utilization at 91%, down from 94% in Q1 2024 due to additional maintenance[22] - Gross crude oil production for Q1 2025 was 413,000 barrels per day, slightly down from 416,000 barrels per day in Q1 2024[46] Capital Expenditures and Projects - Capital and exploration expenditures totaled $398 million, a decrease from $496 million in Q1 2024[11] - Capital and exploration expenditures for Q1 2025 totaled CAD 398 million, down from CAD 496 million in Q1 2024, a decrease of 19.8%[44] - Construction of Canada's largest renewable diesel facility at the Strathcona refinery is on track for startup in mid-2025[4] - The Leming SAGD project is expected to start up in late 2025, with anticipated peak production of around 9,000 barrels per day[11] Asset and Debt Management - Total assets as of March 31, 2025, were CAD 43,889 million, an increase from CAD 42,513 million in the previous year[39] - Total debt decreased to CAD 4,006 million from CAD 4,127 million year-over-year, showing a reduction of 2.9%[39] Cost Management - Cash operating costs for Q1 2025 were CAD 1,947 million, compared to CAD 1,911 million in Q1 2024, reflecting a 1.9% increase[64] - Unit cash operating cost for the Upstream segment in Q1 2025 was CAD 31.31 per oil-equivalent barrel, up from CAD 31.04 in Q1 2024[66] - The Upstream segment's cash operating costs were CAD 1,178 million in Q1 2025, down from CAD 1,189 million in Q1 2024, showing a decrease of 0.9%[64] - The Downstream segment's cash operating costs increased to CAD 631 million in Q1 2025 from CAD 583 million in Q1 2024, a rise of 8.2%[64] Miscellaneous - Chemical net income for the quarter was $31 million, down from $57 million in Q1 2024[11] - There were no identified items impacting net income in Q1 2025 and Q1 2024, providing a clearer view of operational performance[60] - The company reported proceeds from asset sales of CAD 11 million in Q1 2025, up from CAD 4 million in Q1 2024[58] - The company plans to renew its normal course issuer bid in June 2025[6]